The Human Endocrine Pancreas

New Insights on Replacement and Regeneration

Juan Dominguez-Bendala, Giacomo Lanzoni, Dagmar Klein, Silvia Álvarez-Cubela, Ricardo Pastori

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Islet transplantation is an effective cell therapy for type 1 diabetes (T1D) but its clinical application is limited due to shortage of donors. After a decade-long period of exploration of potential alternative cell sources, the field has only recently zeroed in on two of them as the most likely to replace islets. These are pluripotent stem cells (PSCs) (through directed differentiation) and pancreatic non-endocrine cells (through directed differentiation or reprogramming). Here we review progress in both areas, including the initiation of Phase I/II clinical trials using human embryonic stem cell (hESc)-derived progenitors, advances in hESc differentiation in vitro, novel insights on the developmental plasticity of the pancreas, and groundbreaking new approaches to induce β cell conversion from the non-endocrine compartment without genetic manipulation.

Original languageEnglish (US)
Pages (from-to)153-162
Number of pages10
JournalTrends in Endocrinology and Metabolism
Volume27
Issue number3
DOIs
StatePublished - Mar 1 2016

Fingerprint

Islets of Langerhans
Regeneration
Cell Differentiation
Islets of Langerhans Transplantation
Pluripotent Stem Cells
Phase II Clinical Trials
Clinical Trials, Phase I
Cell- and Tissue-Based Therapy
Type 1 Diabetes Mellitus
Pancreas
Human Embryonic Stem Cells
In Vitro Techniques

Keywords

  • Diabetes
  • Human embryonic stem cells
  • Islets
  • Pancreatic regeneration
  • β cells

ASJC Scopus subject areas

  • Endocrinology
  • Endocrinology, Diabetes and Metabolism

Cite this

The Human Endocrine Pancreas : New Insights on Replacement and Regeneration. / Dominguez-Bendala, Juan; Lanzoni, Giacomo; Klein, Dagmar; Álvarez-Cubela, Silvia; Pastori, Ricardo.

In: Trends in Endocrinology and Metabolism, Vol. 27, No. 3, 01.03.2016, p. 153-162.

Research output: Contribution to journalArticle

Dominguez-Bendala, Juan ; Lanzoni, Giacomo ; Klein, Dagmar ; Álvarez-Cubela, Silvia ; Pastori, Ricardo. / The Human Endocrine Pancreas : New Insights on Replacement and Regeneration. In: Trends in Endocrinology and Metabolism. 2016 ; Vol. 27, No. 3. pp. 153-162.
@article{e1f518c0b44b4359bfc7af2501b84b4a,
title = "The Human Endocrine Pancreas: New Insights on Replacement and Regeneration",
abstract = "Islet transplantation is an effective cell therapy for type 1 diabetes (T1D) but its clinical application is limited due to shortage of donors. After a decade-long period of exploration of potential alternative cell sources, the field has only recently zeroed in on two of them as the most likely to replace islets. These are pluripotent stem cells (PSCs) (through directed differentiation) and pancreatic non-endocrine cells (through directed differentiation or reprogramming). Here we review progress in both areas, including the initiation of Phase I/II clinical trials using human embryonic stem cell (hESc)-derived progenitors, advances in hESc differentiation in vitro, novel insights on the developmental plasticity of the pancreas, and groundbreaking new approaches to induce β cell conversion from the non-endocrine compartment without genetic manipulation.",
keywords = "Diabetes, Human embryonic stem cells, Islets, Pancreatic regeneration, β cells",
author = "Juan Dominguez-Bendala and Giacomo Lanzoni and Dagmar Klein and Silvia {\'A}lvarez-Cubela and Ricardo Pastori",
year = "2016",
month = "3",
day = "1",
doi = "10.1016/j.tem.2015.12.003",
language = "English (US)",
volume = "27",
pages = "153--162",
journal = "Trends in Endocrinology and Metabolism",
issn = "1043-2760",
publisher = "Elsevier Inc.",
number = "3",

}

TY - JOUR

T1 - The Human Endocrine Pancreas

T2 - New Insights on Replacement and Regeneration

AU - Dominguez-Bendala, Juan

AU - Lanzoni, Giacomo

AU - Klein, Dagmar

AU - Álvarez-Cubela, Silvia

AU - Pastori, Ricardo

PY - 2016/3/1

Y1 - 2016/3/1

N2 - Islet transplantation is an effective cell therapy for type 1 diabetes (T1D) but its clinical application is limited due to shortage of donors. After a decade-long period of exploration of potential alternative cell sources, the field has only recently zeroed in on two of them as the most likely to replace islets. These are pluripotent stem cells (PSCs) (through directed differentiation) and pancreatic non-endocrine cells (through directed differentiation or reprogramming). Here we review progress in both areas, including the initiation of Phase I/II clinical trials using human embryonic stem cell (hESc)-derived progenitors, advances in hESc differentiation in vitro, novel insights on the developmental plasticity of the pancreas, and groundbreaking new approaches to induce β cell conversion from the non-endocrine compartment without genetic manipulation.

AB - Islet transplantation is an effective cell therapy for type 1 diabetes (T1D) but its clinical application is limited due to shortage of donors. After a decade-long period of exploration of potential alternative cell sources, the field has only recently zeroed in on two of them as the most likely to replace islets. These are pluripotent stem cells (PSCs) (through directed differentiation) and pancreatic non-endocrine cells (through directed differentiation or reprogramming). Here we review progress in both areas, including the initiation of Phase I/II clinical trials using human embryonic stem cell (hESc)-derived progenitors, advances in hESc differentiation in vitro, novel insights on the developmental plasticity of the pancreas, and groundbreaking new approaches to induce β cell conversion from the non-endocrine compartment without genetic manipulation.

KW - Diabetes

KW - Human embryonic stem cells

KW - Islets

KW - Pancreatic regeneration

KW - β cells

UR - http://www.scopus.com/inward/record.url?scp=84958105321&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84958105321&partnerID=8YFLogxK

U2 - 10.1016/j.tem.2015.12.003

DO - 10.1016/j.tem.2015.12.003

M3 - Article

VL - 27

SP - 153

EP - 162

JO - Trends in Endocrinology and Metabolism

JF - Trends in Endocrinology and Metabolism

SN - 1043-2760

IS - 3

ER -